General Information of the Compound
Compound ID
CP0887621
Compound Name
3-(4-(1-methyl-1H-imidazol-5-yl)-1H-1,2,3-triazol-1-yl)-N-m-tolylbenzamide
    Show/Hide
Structure
Formula
C20H18N6O
Molecular Weight
358.405
Canonical SMILES
Cc1cccc(NC(=O)c2cccc(-n3cc(-c4cncn4C)nn3)c2)c1
    Show/Hide
InChI
InChI=1S/C20H18N6O/c1-14-5-3-7-16(9-14)22-20(27)15-6-4-8-17(10-15)26-12-18(23-24-26)19-11-21-13-25(19)2/h3-13H,1-2H3,(H,22,27)
    Show/Hide
InChIKey
GMHLDODISHFXDZ-UHFFFAOYSA-N
Physicochemical Property
logP
3.22852
Rotatable Bonds
4
Heavy Atom Count
27
Polar Areas
77.63
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 146293961
ChEMBL ID
CHEMBL4751970
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06102, Probable G-protein coupled receptor 142
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 0.37 nM
   TI
   LI
   LO
   TS